Filing Details

Accession Number:
0001209191-19-031424
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-20 16:38:13
Reporting Period:
2019-05-16
Accepted Time:
2019-05-20 16:38:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE Biological Products, (No Disgnostic Substances) (2836) 203435077
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640869 Nancy Krueger 3545 John Hopkins Court, Suite 250
San Diego CA 92121
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-16 12,500 $0.00 29,999 No 4 M Direct
Common Stock Disposition 2019-05-17 4,651 $0.45 25,348 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-05-16 12,500 $0.00 12,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 No 4 M Direct
Footnotes
  1. Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on May 16, 2018.
  2. Includes 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on May 15, 2019.
  3. Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018.
  4. The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019.